FOR IMMEDIATE RELEASE

INTERVIEWS AND PHOTOS AVAILABLE UPON REQUEST

MEDIA CONTACTS: Allison Foullois, Epsen Fuller | IMD, 973/359-9929, x 305 allison@epsenfuller.com  

EPSEN FULLER | IMD AWARDED KEY SEARCH
FOR INTERNATIONAL PHARMACEUTICAL GROUP

Morristown, NJ (October 25, 2005) – The Pierre Fabre Group, the  2nd largest independent pharmaceutical group in France with total sales reaching USD 1.83B in 2004 in 130 countries and headquartered in Paris, recently tapped executive search firm Epsen Fuller | IMD to conduct a critical search for their US headquarters located in Parsippany, NJ.  Berthe De Vos, managing director, Europe for Epsen Fuller | IMD, will lead the search for a vice president & commercial director, for Pierre Fabre Oncologie and will be assisted by Marie-Paule McNeice, senior consultant of the firm. 

The charter of the vice president & commercial director will be to re-launch Navelbine I.V., a drug used for the treatment of lung cancer and breast cancer, in the US and Canada under the Pierre Fabre Oncologie license by building on the reputation the drug acquired during the 10-year licensing agreement with GSK.  The position, requiring extensive domestic and international travel and a working knowledge of the French language, will report to the managing director of Pierre Fabre Medicaments based in Paris, France. 

“This is a unique opportunity for the right person.” says Berthe De Vos, managing director, Europe for Epsen Fuller | IMD.  “There is tremendous growth in the drug discovery industry and Pierre Fabre is passionate about their commitment to research and development for cancer patients.” 

This reinforces the strong international presence of Epsen Fuller and our IMD International Search Partnership" commented Thomas Fuller, General Managing Partner of Epsen Fuller | IMD.  "With our global reach, an international assignment such as this one for Pierre Fabre Oncologie, further demonstrates our borderless search capabilities and the value we bring to our multi-national clients."
 
About The Pierre Fabre Group.  The Pierre Fabre Group, www.pierre-fabre.com, the second-largest independent laboratory in France, employs about 9,300 people and achieved sales of 1.47 billion euros in 2004.  Operating in the areas of ethical medicine, health products and dermo-cosmetics with the brands Avene, Ducray, A-derma, Galenic, Klorane and Rene Furterer, it achieves 43 percent of its business abroad.  With more than 1,100 researchers, Pierre Fabre Medicament dedicates 23 percent of its annual sales to research and development in five major therapeutic areas in terms of public health: oncology (the priority R&D area of Pierre Fabre Medicament with 50% of all R&D expenses), central nervous system, cardiology, internal medicine/urology and dermatology.

About Epsen Fuller | IMD.  Headquartered in Morristown, New Jersey with offices in New York, Epsen Fuller | IMD, www.epsenfuller.com, is a retained executive search firm with global reach and borderless search technology.  Utilizing their proprietary Human Capital Valuation SystemSM to ensure exceptional results in defining client requirements and assessing candidate fit for the position, Epsen Fuller | IMD conducts assignments for senior management talent throughout the technology, life science, consumer products and professional services industries. 

###

Human Capital Valuation SystemSM   is a registered service mark of Epsen Fuller | IMD.